Cargando…
A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19
Background: A large number of people contracted moderate-type COVID-19 around the world. However, to our knowledge no studies have covered the clinical course of patients with moderate-type COVID-19. This study describes the clinical course of moderate-type patients with COVID-19 from Wuhan City and...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112071/ https://www.ncbi.nlm.nih.gov/pubmed/33987158 http://dx.doi.org/10.3389/fpubh.2021.593109 |
_version_ | 1783690624041484288 |
---|---|
author | Liao, Xiaohua Lv, Xin Song, Cheng Jiang, Mao He, Ronglin Han, Yuanyuan Li, Mengyu Zhang, Yan Jiang, Yupeng Meng, Jie |
author_facet | Liao, Xiaohua Lv, Xin Song, Cheng Jiang, Mao He, Ronglin Han, Yuanyuan Li, Mengyu Zhang, Yan Jiang, Yupeng Meng, Jie |
author_sort | Liao, Xiaohua |
collection | PubMed |
description | Background: A large number of people contracted moderate-type COVID-19 around the world. However, to our knowledge no studies have covered the clinical course of patients with moderate-type COVID-19. This study describes the clinical course of moderate-type patients with COVID-19 from Wuhan City and Yiyang City, and explores factors relevant to the length of hospitalization and symptoms relief. Methods: The study analyzed the clinical course of 107 moderate-type patients with COVID-19 from the outbreak area (Wuhan) and the imported area (Yiyang), and used automatic linear modeling and multivariate linear regression analysis to explore the factors relevant to the length of hospitalization and symptoms relief. Furthermore, we created a scoring system to value the length of hospitalization and symptoms relief. Results: Lymphopenia, elevated C-reactive protein, increased LDH, bilateral lung GGO (ground glass opacity), and lung consolidation were more likely to appear in ordinary inpatients with moderate-type COVID-19 from Wuhan (P < 0.05), compared to infected medical staff from Wuhan and ordinary inpatients with moderate-type COVID-19 from Yiyang. Meanwhile, the length of hospitalization and symptoms relief was longer in ordinary patients with moderate-type COVID-19 from Wuhan (P < 0.05). Onset of symptoms to admission, ESR, leucocytes count, and bilateral lung GGO were linearly related to the length of hospitalization (P < 0.05); onset of symptoms to admission, leucocytes count, bilateral lung GGO, and lung consolidation were linearly related to the length of symptoms relief (P < 0.05). By using the scoring system, we found that the time of hospitalization and symptoms relief lengthened as the scores increased. Conclusions: This study described the clinical course of patients with moderate-type COVID-19, and found that ordinary patients with moderate-type COVID-19 in outbreak areas were more serious and needed stronger treatment and longer treatment time. Onset of symptoms to admission, ESR, leucocytes count, and bilateral lung GGO can be effective predictors of the length of hospitalization. And onset of symptoms to admission, leucocytes count, bilateral lung GGO, and lung consolidation can be effective predictors of the amount of time until symptoms relief. Most importantly, we have created a scoring system, which could contribute to the diagnosis and treatment of COVID-19. |
format | Online Article Text |
id | pubmed-8112071 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81120712021-05-12 A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 Liao, Xiaohua Lv, Xin Song, Cheng Jiang, Mao He, Ronglin Han, Yuanyuan Li, Mengyu Zhang, Yan Jiang, Yupeng Meng, Jie Front Public Health Public Health Background: A large number of people contracted moderate-type COVID-19 around the world. However, to our knowledge no studies have covered the clinical course of patients with moderate-type COVID-19. This study describes the clinical course of moderate-type patients with COVID-19 from Wuhan City and Yiyang City, and explores factors relevant to the length of hospitalization and symptoms relief. Methods: The study analyzed the clinical course of 107 moderate-type patients with COVID-19 from the outbreak area (Wuhan) and the imported area (Yiyang), and used automatic linear modeling and multivariate linear regression analysis to explore the factors relevant to the length of hospitalization and symptoms relief. Furthermore, we created a scoring system to value the length of hospitalization and symptoms relief. Results: Lymphopenia, elevated C-reactive protein, increased LDH, bilateral lung GGO (ground glass opacity), and lung consolidation were more likely to appear in ordinary inpatients with moderate-type COVID-19 from Wuhan (P < 0.05), compared to infected medical staff from Wuhan and ordinary inpatients with moderate-type COVID-19 from Yiyang. Meanwhile, the length of hospitalization and symptoms relief was longer in ordinary patients with moderate-type COVID-19 from Wuhan (P < 0.05). Onset of symptoms to admission, ESR, leucocytes count, and bilateral lung GGO were linearly related to the length of hospitalization (P < 0.05); onset of symptoms to admission, leucocytes count, bilateral lung GGO, and lung consolidation were linearly related to the length of symptoms relief (P < 0.05). By using the scoring system, we found that the time of hospitalization and symptoms relief lengthened as the scores increased. Conclusions: This study described the clinical course of patients with moderate-type COVID-19, and found that ordinary patients with moderate-type COVID-19 in outbreak areas were more serious and needed stronger treatment and longer treatment time. Onset of symptoms to admission, ESR, leucocytes count, and bilateral lung GGO can be effective predictors of the length of hospitalization. And onset of symptoms to admission, leucocytes count, bilateral lung GGO, and lung consolidation can be effective predictors of the amount of time until symptoms relief. Most importantly, we have created a scoring system, which could contribute to the diagnosis and treatment of COVID-19. Frontiers Media S.A. 2021-04-26 /pmc/articles/PMC8112071/ /pubmed/33987158 http://dx.doi.org/10.3389/fpubh.2021.593109 Text en Copyright © 2021 Liao, Lv, Song, Jiang, He, Han, Li, Zhang, Jiang and Meng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Liao, Xiaohua Lv, Xin Song, Cheng Jiang, Mao He, Ronglin Han, Yuanyuan Li, Mengyu Zhang, Yan Jiang, Yupeng Meng, Jie A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title | A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title_full | A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title_fullStr | A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title_full_unstemmed | A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title_short | A Retrospective Cohort Study on the Clinical Course of Patients With Moderate-Type COVID-19 |
title_sort | retrospective cohort study on the clinical course of patients with moderate-type covid-19 |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112071/ https://www.ncbi.nlm.nih.gov/pubmed/33987158 http://dx.doi.org/10.3389/fpubh.2021.593109 |
work_keys_str_mv | AT liaoxiaohua aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT lvxin aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT songcheng aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT jiangmao aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT heronglin aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT hanyuanyuan aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT limengyu aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT zhangyan aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT jiangyupeng aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT mengjie aretrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT liaoxiaohua retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT lvxin retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT songcheng retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT jiangmao retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT heronglin retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT hanyuanyuan retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT limengyu retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT zhangyan retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT jiangyupeng retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 AT mengjie retrospectivecohortstudyontheclinicalcourseofpatientswithmoderatetypecovid19 |